Topics

Roche's Tecentriq Shows Promise for Progression-Free Survival in Bladder Cancer

20:00 EDT 4 Aug 2019 | BioSpace

Roche announced interim results from its Phase III IMvigor130 clinical trial, indicating it met its co-primary endpoint of progression-free survival. The trial evaluated the combination of Tecentriq and platinum-based chemotherapy in previously untreated locally advanced or metastatic urothelial ...

Original Article: Roche's Tecentriq Shows Promise for Progression-Free Survival in Bladder Cancer

NEXT ARTICLE

More From BioPortfolio on "Roche's Tecentriq Shows Promise for Progression-Free Survival in Bladder Cancer"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...